Theodore R Schroeder Nabriva Therapeutics PLC (NBRV) insider trading activity

Theodore R Schroeder is Director of Nabriva Therapeutics plc. Currently has a direct ownership of 11,989 shares of NBRV, which is worth approximately $4,795. The most recent transaction as insider was on Jan 29, 2022, when has been sold 10,766 shares (Ordinary Shares) at a price of $0.45 per share, resulting in proceeds of $4,845. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12K

0% 3M change

0% 12M change

Total Value Held $4,795

Theodore R Schroeder Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 29 2022	SELL Payment of exercise price or tax liability	$4,845 $0.45 p/Share	10,766 Reduced 3.31%	314,736 Ordinary Shares
Jan 06 2022	SELL Payment of exercise price or tax liability	$157 $0.58 p/Share	270 Reduced 0.08%	325,502 Ordinary Shares
Dec 31 2021	SELL Payment of exercise price or tax liability	$64 $0.6 p/Share	107 Reduced 0.03%	325,772 Ordinary Shares
Dec 28 2021	BUY Open market or private purchase	$57,000 $0.57 p/Share	100,000 Added 23.48%	325,879 Ordinary Shares
Dec 06 2021	SELL Payment of exercise price or tax liability	$162 $0.72 p/Share	225 Reduced 0.1%	225,879 Ordinary Shares
Nov 30 2021	SELL Payment of exercise price or tax liability	$83 $0.78 p/Share	107 Reduced 0.05%	226,104 Ordinary Shares
Nov 06 2021	SELL Payment of exercise price or tax liability	$299 $1.33 p/Share	225 Reduced 0.1%	226,211 Ordinary Shares
Oct 31 2021	SELL Payment of exercise price or tax liability	$123 $1.15 p/Share	107 Reduced 0.05%	226,436 Ordinary Shares
Oct 06 2021	SELL Payment of exercise price or tax liability	$243 $1.08 p/Share	225 Reduced 0.1%	226,543 Ordinary Shares
Sep 30 2021	SELL Payment of exercise price or tax liability	$127 $1.19 p/Share	107 Reduced 0.05%	226,768 Ordinary Shares
Sep 14 2021	BUY Open market or private purchase	$56,500 $1.13 p/Share	50,000 Added 18.06%	226,875 Ordinary Shares
Sep 06 2021	SELL Payment of exercise price or tax liability	$250 $1.11 p/Share	225 Reduced 0.13%	176,875 Ordinary Shares
Aug 31 2021	SELL Payment of exercise price or tax liability	$113 $1.06 p/Share	107 Reduced 0.06%	177,100 Ordinary Shares
Aug 06 2021	SELL Payment of exercise price or tax liability	$263 $1.17 p/Share	225 Reduced 0.13%	177,207 Ordinary Shares
Jul 31 2021	SELL Payment of exercise price or tax liability	$118 $1.1 p/Share	107 Reduced 0.06%	177,432 Ordinary Shares
Jul 06 2021	SELL Payment of exercise price or tax liability	$286 $1.27 p/Share	225 Reduced 0.13%	177,539 Ordinary Shares
Jun 30 2021	SELL Payment of exercise price or tax liability	$144 $1.35 p/Share	107 Reduced 0.06%	177,764 Ordinary Shares
Jun 06 2021	SELL Payment of exercise price or tax liability	$302 $1.34 p/Share	225 Reduced 0.13%	177,871 Ordinary Shares
May 31 2021	SELL Payment of exercise price or tax liability	$148 $1.38 p/Share	107 Reduced 0.06%	178,096 Ordinary Shares
May 06 2021	SELL Payment of exercise price or tax liability	$335 $1.49 p/Share	225 Reduced 0.13%	178,203 Ordinary Shares
Apr 30 2021	SELL Payment of exercise price or tax liability	$190 $1.78 p/Share	107 Reduced 0.06%	178,428 Ordinary Shares
Apr 06 2021	SELL Payment of exercise price or tax liability	$389 $1.73 p/Share	225 Reduced 0.13%	178,535 Ordinary Shares
Mar 31 2021	SELL Payment of exercise price or tax liability	$178 $1.66 p/Share	107 Reduced 0.06%	181,680 Ordinary Shares
Mar 06 2021	SELL Payment of exercise price or tax liability	$403 $1.79 p/Share	225 Reduced 0.13%	178,760 Ordinary Shares
Feb 28 2021	SELL Payment of exercise price or tax liability	$253 $2.39 p/Share	106 Reduced 0.06%	181,787 Ordinary Shares

Also insider at

OTIC

OTONOMY, INC. Healthcare

Director

CDTX

Cidara Therapeutics, Inc. Healthcare

Director

PHAT

Phathom Pharmaceuticals, Inc. Healthcare

TRS